Charles (Chuck) Maack Posted November 13, 2017 Share Posted November 13, 2017 I personally had recommended Jim Marshall, and I would hope that those of you receiving this email keep in mind come 2018 to join together and send several, individual, recommendations to PCRI nominating Jim for the Harry Pinchot Award since Jim is certainly deserving of this recognition for all he has done for Prostate Cancer Advocacy, Awareness, government awareness, medication coverage, and improved treatment for men diagnosed with this insidious disease in Australia. Harry Pinchot was the Prostate Cancer Patient for whom the Prostate Cancer Research Institute “PCRI Annual Harry Pinchot Award” came to be. Harry, with advanced Prostate Cancer at diagnosis, fought his cancer for thirteen years before succumbing to this insidious men’s disease. In the meantime, Harry, rather than accept the conclusions of various physicians who anticipated he had only months to possibly a year or two left to live, involved himself in deep research and study of Prostate Cancer to determine for himself what should be his most appropriate treatment. At the same time, he became PCRI’s Program Director for over a decade, and was known as “Helpline Harry” because he was always taking calls from concerned prostate cancer patients. His devotion to the mission of educating men and highlighting the plight of those affected by the disease earned him national recognition. Please open the attachment to hear Harry’s poignant reflection on his journey with Prostate Cancer. https://youtu.be/aiPtV2JGKxQ During this period of Harry’s journey and involvement to help others, I, too, was similarly involved, but personally with the development of my website www.theprostateadvocate.com as an advocate regarding Prostate Cancer and as a Mentor working online voluntarily with patients and their caregivers throughout the world. Being honored in 2012 as a recipient of the “PCRI Annual Harry Pinchot Award” was very humbling and I could not help but feel at that time that Harry would have been proud that I had been following his similar path. This year, 2017, Steve Hentzen of Kansas City, a co-founder of Prostate Network https://www.prostatenetwork.org/, was honored with this prestigious award. The notation that comes with the award recognizes “accomplishments and personal attributes that show excellence in prostate cancer education, research, advocacy, and community support.” Prostate Cancer Networking Group www.prostatenetwork.org We invite all prostate cancer survivors, their partners and those helping in the fight to join us. The Prostate Advocate www.theprostateadvocate.com The Prostate Advocate website is dedicated to providing useful resources towards understanding prostate cancer, its treatment, and the treatment of the side effects ... Charles (Chuck) Maack - Prostate Cancer Patient/Activist/Reduced Activity as Mentor (Because of age related health issues, had to limit what had been worldwide daily mentoring) (A mentor should be someone who offers courtesy, professionalism, respect, wisdom, knowledge, and support to help you achieve your goals; would that I succeed) Always as close as the other end of your computer to help address any prostate cancer concerns. "What you leave behind is not what is engraved in stone monuments, but what is woven into the lives of others." “A good character is the best tombstone. Those who loved you will remember. Carve your name on hearts, not on marble.” “Sepius Exertus, Semper Paratus, Semper Fortis, Semper Fidelis, Fraters Infinitas” “Often tested, Always Prepared, Always Courageous, Always Faithful, Brothers Forever" Recipient 2008 Us TOO Intl., Inc., Prostate Education & Support Network 1st “Edward C. Kaps Hope Award” Recipient 2012 Prostate Cancer Research Institute (PCRI) “Harry Pinchot Award” Recipient 2016 Us TOO Intl., Inc. Certificate for 20 Years Dedication/Inspiration Email: firstname.lastname@example.org My website http://www.theprostateadvocate.com In my Lord I put my trust… Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.